Unprecedented OS with the addition of tarlatamab to first-line maintenance therapy for ES-SCLC
Nature · By David Killock ·
Nature Reviews Clinical Oncology, Published online: 06 November 2026; doi:10.1038/s41571-026-01227-x Unprecedented OS with the addition of tarlatamab to first-line maintenance therapy for ES-SCLC